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Abstract: Ciguatera Fish Poisoning (CFP) is a human illness caused by the consumption of marine
fish contaminated with ciguatoxins (CTX) and possibly maitotoxins (MTX), produced by species
from the benthic dinoflagellate genus Gambierdiscus. Here, we describe the identity and toxicology of
Gambierdiscus spp. isolated from the tropical and temperate waters of eastern Australia. Based on
newly cultured strains, we found that four Gambierdiscus species were present at the tropical location,
including G. carpenteri, G. lapillus and two others which were not genetically identical to other
currently described species within the genus, and may represent new species. Only G. carpenteri was
identified from the temperate location. Using LC-MS/MS analysis we did not find any characterized
microalgal CTXs (P-CTX-3B, P-CTX-3C, P-CTX-4A and P-CTX-4B) or MTX-1; however, putative
maitotoxin-3 (MTX-3) was detected in all species except for the temperate population of G. carpenteri.
Using the Ca2+ influx SH-SY5Y cell Fluorescent Imaging Plate Reader (FLIPR) bioassay we found
CTX-like activity in extracts of the unidentified Gambierdiscus strains and trace level activity in strains
of G. lapillus. While no detectable CTX-like activity was observed in tropical or temperate strains of
G. carpenteri, all species showed strong maitotoxin-like activity. This study, which represents the most
comprehensive analyses of the toxicology of Gambierdiscus strains isolated from Australia to date,
suggests that CFP in this region may be caused by currently undescribed ciguatoxins and maitotoxins.
Keywords: Benthic Harmful Algal Bloom (BHAB); Ciguatera Fish Poisoning (CFP); Ciguatoxin (CTX);
Fluorescent Imaging Plate Reader (FLIPR); Liquid Chromatography-Tandem Mass Spectrometry
(LC-MS/MS); Maitotoxin (MTX)
1. Introduction
Ciguatera Fish Poisoning (CFP) is a human illness which arises from the consumption of marine
fish contaminated with ciguatoxins (CTX) [1]. Globally, it is estimated that between 50,000 and
200,000 people each year are affected [2], making it the most prevalent nonbacterial human illness
associated with seafood consumption [3,4]. The risk of CFP is higher in tropical locations and is
particularly prevalent among island communities who rely on seafood for survival [5,6], affecting up to
2000 per 100,000 people each year [7]. However, with the onset of international travel and worldwide
seafood trade, this foodborne syndrome has now become a global issue [8–10].
Some species of dinoflagellates from the genus Gambierdiscus produce CTXs, the causative agents
of CFP [11]. Adachi and Fukuyo [12] originally described Gambierdiscus toxicus, the first species in the
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genus, from samples collected in the Gambier Islands, French Polynesia. For many years, the genus
was thought to be monotypic; however, increased interest and the application of molecular techniques
toward identification procedures has led to its reclassification into at least 15 Gambierdiscus species and
five sub-groups [13–16]. Targeted sampling and continued research will likely reveal more diversity
in the future. The identification of Gambierdiscus species based on thecal plate morphology is very
challenging, as the differences between species are subtle and largely overlap [12,17–19]. Assessment
of the phylogenetic relationships of species based on particular genetic markers constitutes additional
information for species identification [13,19]. Phylogenetic analysis of Gambierdiscus is primarily
inferred from the nuclear-encoded ribosomal RNA gene (rDNA), including multiple regions of the
large subunit (LSU D1–D3 and LSU D8–D10) [13,19], the small subunit (SSU) or the internal transcribed
spacer (ITS) [13].
CTXs are highly potent, lipophilic, polyether toxins which affect mammalian cells by activating
voltage gated sodium channels [20–22]. Different structural forms of CTXs can be produced by
Gambierdiscus species (e.g., P-CTX-3B, P-CTX-3C, P-CTX-4A, P-CTX-4B), each displaying differing
toxicities [23]. Furthermore, CTXs isolated from marine fish are different from those produced
by Gambierdiscus species [24,25] and can differ between locations (e.g., Atlantic Ocean vs. Pacific
Ocean) [26–29]. Maitotoxins (MTXs) are also produced by species of Gambierdiscus [30]. These large,
potent polyether toxins enhance intracellular calcium levels [31–33] and are amongst the most lethal
non-proteinaceous natural compounds known [34].
Routine monitoring of toxins (particularly CTXs) produced by Gambierdiscus species is complicated
by the many structural differences in the natural products produced, typically low observable
quantities, and the lack of adequate reference standards [1]. Currently, there is, no validated
unified approach for evaluating the toxicity of Gambierdiscus strains. Traditionally, the most common
assessment of Gambierdiscus toxicity was via the mouse bioassay [19,23]. This involves administering
the extracted toxin intraperitoneally or orally to Swiss albino mice, observing the symptomatology
and calculating the median lethal dose (LD50) [35]. This method however is non-specific and does
not allow identification of the compound responsible for the observed toxicity. More recently,
mammalian cell-based assays have been developed which assess the toxicity of a microalgal
extract and provide a degree of differentiation amongst toxin classes. These include neuroblastoma
(neuro-2a) cytotoxicity [36]; human erythrocyte lysis [37] and the Ca2+ influx SH-SY5Y cell Fluorescent
Imaging Plate Reader (FLIPR) bioassay [38]. Liquid Chromatography-Tandem Mass Spectrometry
(LC-MS/MS) is another analytical technique that provides the most specific evaluation of toxins
but is limited by the number of forms for which standards are available. This method can detect
microalgal-derived characterized toxins such as P-CTX-3B, P-CTX-3C, P-CTX4A, P-CTX4B, MTX-1
and putative MTX-3 [39–41].
There have been large outbreaks of CFP in Australia, with two human fatalities and more
than 1400 documented cases between 1965 and 2010 [42,43]. Outbreaks primarily occurred in
Queensland [42,44,45] and the Northern Territory [46], with one case from Victoria traced back to
the consumption of a Maori wrasse (Cheilinus undulates) imported from the Great Barrier Reef [46].
More recently, there have been multiple cases of ciguatera in northern New South Wales, linked with
the consumption of locally caught Spanish mackerel (Scomberomorus commerson) contaminated with
P-CTX-1B [47].
Within Australia, the presence of Gambierdiscus has been documented throughout the Great Barrier
Reef, Queensland [48–52], at Exmouth in Western Australia [53] and at several sites in temperate
locations in New South Wales [54]. However, complete identification of the species and toxicology
analyses were not included in these studies. Work to characterize the diversity within Australia is
underway, with G. carpenteri and a species much like G. belizeanus described at several locations in
the Great Barrier Reef [55,56], as well as G. carpenteri being documented at Merimbula and Wapengo
Lagoon, New South Wales [57]. Interestingly, the species of Gambierdiscus found in Exmouth, Western
Australia was similar to G. carpenteri [53], suggesting this species is well adapted to Australian
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conditions and may be widely distributed. More recently, G. lapillus was described from samples
collected at Heron Island [58] and a previously unidentified strain of Gambierdiscus from the same
location [15] was reclassified as a new species, G. honu [40]. Although our understanding of the identity
of Gambierdiscus species in Australia is advancing, very little is known about their toxicology (Table 1).
Table 1. Toxicology of Gambierdiscus species documented from the Australian region. NA denotes
information is not available.
Species Location Toxicity LC-MS/MS Profile Reference
G. cf. belizeanus Heron Island, Queensland NA NA [55]
G. carpenteri
Townsville, Queensland NA NA [55,56]
Merimbula and Wapengo
Lagoon, New South Wales NA
No CTX-3B, -3C, -4A, -4B
No MTX-1, or MTX-3 [57]
G. honu Heron Island, Queensland NA NA [15,40]
G. lapillus Heron Island, Queensland NA




G. toxicus * Arlington Reef, QueenslandPlatypus Bay, Queensland Positive NA [49]
* The identification of G. toxicus is not certain as the study occurred prior to revision of the genus.
In this study, single cells of Gambierdiscus from tropical and temperate Australia were isolated,
and monoclonal cultures established. To verify their identity to species level, DNA was extracted from
cultures and the D1–D3 and D8–D10 regions of the large subunit ribosomal RNA gene were sequenced.
Toxicity was assessed using LC-MS/MS and the Ca2+ influx SH-SY5Y cell FLIPR bioassay, advancing
our understanding of the organisms which contribute to CFP in Australia.
2. Results
2.1. Strain Identification
Maximum Likelihood and Bayesian analyses of the LSU rDNA D1–D3 and D8–D10 regions
provided evidence to support the clades described in Nishimura et al. [59] for Gambierdiscus species.
All five temperate strains of Gambierdiscus (UTSMER9A3, UTSMER8B4, UTSMER7A1, UTSMER1A3,
UTSMER8A4) and four tropical strains (UTSHI2C4, UTSHI6C3, UTSHI6A1, UTSHI6D2), group with
other strains of G. carpenteri in both phylogenies with high support (Figure 1a,b). Therefore, most of
the isolates collected from eastern Australia were identified as G. carpenteri (Table 2). Three strains
(UTSHI6B5, UTSHI2B6, UTSHI2B5) group with high support in the LSU rDNA D8–D10 region
phylogeny with G. lapillus (Figure 1b), a new species described from the same tropical location
in eastern Australia (Heron Island) [58]. Sequences were not available however, to compare the
LSU rDNA D1–D3 region phylogeny. Strain UTSHI6A6 groups within clade V, the most diverse
Gambierdiscus clade [59], in both LSU gene phylogenies. This strain is closely related to, but distinct
from, G. pacificus strains from around the world (Figure 1a,b). Similarly, strain UTSHI6B1 groups
within clade III [59] and is closely related to G. silvae in both phylogenies, but also forms a distinct
cluster (Figure 1a,b). More analyses are required to fully describe these strains and both are therefore
referred to as Gambierdiscus sp. in this study.
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Figure 1. Maximum Likelihood phylogenetic tree showing alignment of the D1–D3 region (a) and the 
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Analysis of the Gambierdiscus culture extracts using LC-MS/MS did not reveal the presence of 
the microalgal-derived ciguatoxins P-CTX-3B, P-CTX-3C, P-CTX-4A and P-CTX-4B (for which we 
had calibration standards), or MTX-1, in any of the strains isolated in this study. Putative MTX-3 was 
detected in all tropical strains of Gambierdiscus including G. carpenteri, but was absent from all 
temperate strains of the same species (Table 2). These toxin profiles did not change when the cultures 
were grown at 18 or 27 °C (Table 2). Tropical strains of G. carpenteri produced MTX-3 at temperatures 
as low as 18 °C and at 27 °C and the temperate cultures did not produce MTX-3 at either temperature. 
2.3. Presence of Ciguatoxin (CTX) and Maitotoxin-Like (MTX) Activities in Isolated Strains 
The Ca2+ influx SH-SY5Y cell FLIPR bioassay [38] showed distinct CTX-like activities (i.e., post 
veratridine addition) in several of the High Performance Liquid Chromatography (HPLC) fractions 
from the dichloromethane phase of three of the four Gambierdiscus species. Two strains, Gambierdiscus 
sp. (UTSHI6A6) and Gambierdiscus sp. (UTSHI6B1), showed clear CTX-like activities (Figure 2g,h, 
Table 2) and low levels of CTX-like activity were also detected in both strains of G. lapillus (Figure 
2e,f). No distinct CTX-like activity was detected for tropical or temperate strains of G. carpenteri 
Figure 1. Maximum Likelihood phylogenetic tree showing alignment of the D1–D3 region (a) and
the D8–D10 region (b) of the large subunit (LSU) rDNA sequences. Strains from this study are
shown in bold. Values at nodes represent Bayesian posterior probability and Maximum Likelihood
bootstrap support.
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Table 2. Geographic origin and toxicity of Gambierdiscus strains established in this study. All strains were grown at 24 ◦C for toxin analysis. Strains listed with
temperatures (e.g., 18 ◦C and 27 ◦C), indicate additional growth temperatures that were tested. For the LC-MS/MS analysis, ND denotes toxins not detected. For the
Ca 2+ influx SH-SY5Y cell FLIPR bioassay, results are shown as the number of CTX- and MTX-like peaks of activity and NA signifies strains which were not analysed.
Species Name Site of Isolation Strain Number
Genbank Accession No. LC-MS/MS Ca
2+ Influx SH-SY5Y
Cell FLIPR Bioassay




Heron Island Lagoon, Australia UTSHI2C4 MG280880 MG280866
ND MTX-3 0 3
Tropical G. carpenteri (18 ◦C) ND MTX-3 NA NA
Tropical G. carpenteri (27 ◦C) ND MTX-3 NA NA
Tropical G. carpenteri Heron Island Lagoon, Australia UTSHI6C3 MG280881 MG280869 ND MTX-3 0 4
Tropical G. carpenteri Heron Island Lagoon, Australia UTSHI6A1 MG280883 MG280872 ND MTX-3 NA NA
Tropical G. carpenteri Heron Island Lagoon, Australia UTSHI6D2 MG280884 MG280873 ND MTX-3 NA NA
Temperate G. carpenteri
Merimbula Inlet, Australia UTSMER9A3 MG280889 MG280878
ND ND 0 4
Temperate G. carpenteri (18 ◦C) ND ND NA NA
Temperate G. carpenteri (27 ◦C) ND ND NA NA
Temperate G. carpenteri Merimbula Inlet, Australia UTSMER8B4 MG280886 MG280875 ND ND 0 4
Temperate G. carpenteri Merimbula Inlet, Australia UTSMER7A1 MG280887 MG280876 ND ND NA NA
Temperate G. carpenteri Merimbula Inlet, Australia UTSMER1A3 MG280888 MG280877 ND ND NA NA
Temperate G. carpenteri Merimbula Inlet, Australia UTSMER8A4 MG280890 MG280879 ND ND NA NA
G. lapillus Heron Island Lagoon, Australia UTSHI6B5 MG280867 ND MTX-3 1 3
G. lapillus Heron Island Lagoon, Australia UTSHI2B6 MG280868 ND MTX-3 1 2
G. lapillus Heron Island Lagoon, Australia UTSHI2B5 MG280871 ND MTX-3 NA NA
Gambierdiscus sp. Heron Island Lagoon, Australia UTSHI6A6 MG280882 MG280870 ND MTX-3 1 2
Gambierdiscus sp. Heron Island Lagoon, Australia UTSHI6B1 MG280885 MG280874 ND MTX-3 1 3
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2.2. Detection of Characterized Ciguatoxins (CTXs) and Maitotoxins (MTXs)
Analysis of the Gambierdiscus culture extracts using LC-MS/MS did not reveal the presence of
the microalgal-derived ciguatoxins P-CTX-3B, P-CTX-3C, P-CTX-4A and P-CTX-4B (for which we
had calibration standards), or MTX-1, in any of the strains isolated in this study. Putative MTX-3
was detected in all tropical strains of Gambierdiscus including G. carpenteri, but was absent from all
temperate strains of the same species (Table 2). These toxin profiles did not change when the cultures
were grown at 18 or 27 ◦C (Table 2). Tropical strains of G. carpenteri produced MTX-3 at temperatures
as low as 18 ◦C and at 27 ◦C and the temperate cultures did not produce MTX-3 at either temperature.
2.3. Presence of Ciguatoxin (CTX) and Maitotoxin-Like (MTX) Activities in Isolated Strains
The Ca2+ influx SH-SY5Y cell FLIPR bioassay [38] showed distinct CTX-like activities (i.e., post
veratridine addition) in several of the High Performance Liquid Chromatography (HPLC) fractions
from the dichloromethane phase of three of the four Gambierdiscus species. Two strains, Gambierdiscus
sp. (UTSHI6A6) and Gambierdiscus sp. (UTSHI6B1), showed clear CTX-like activities (Figure 2g,h,
Table 2) and low levels of CTX-like activity were also detected in both strains of G. lapillus (Figure 2e,f).
No distinct CTX-like activity was detected for tropical or temperate strains of G. carpenteri (Figure 2a–d).
MTX-like activity was detected in fractions eluted at 42–45 min in extracts of all species except
UTSMER9A3, one of the temperate strains of G. carpenteri (Figure 2d). CTX-like activity was also
detected in the fractions eluted prior to, during and following this MTX-like activity peak (Figure 2).
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Figure 2. Ciguatoxin-like (red) and maitotoxin-like (blue) activities of the High Performance Liquid 
Chromatography (HPLC) fractionated (black trace) dichloromethane phase of extracts from 
Gambierdiscus strains isolated in this study. 
In comparison to the variable CTX-like activities amongst strains, strong MTX-like activities 
were detected in all Gambierdiscus strains tested. There was a distinct peak in the earliest fractions of 
Figure 2. Ciguatoxin-like (red) and m itotoxin-like (blu ) activities of the High Performance
Liquid Chromatography (HPLC) fractionated (black trace) dichloromethane phase of extracts from
Gambierdiscus strains isolated in this study.
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In comparison to the variable CTX-like activities amongst strains, strong MTX-like activities were
detected in all Gambierdiscus strains tested. There was a distinct peak in the earliest fractions of the
HPLC-fractionated methanol phase and large activity in the fractions eluted between 30 and 60 min for
all extracts (Figure 3). All the strains of G. carpenteri from both tropical and temperate Australia showed
additional MTX-like activity peaks (Table 2) in fractions eluted between 10 and 30 min (Figure 3).
CTX-like activity was also detected in most extracts, prior to and following strong MTX-like activity
(Figure 3).
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Figure 3. Ciguatoxin-like (red) and maitotoxin-like (blue) activities of the HPLC fractionated
(black trace) methanol phase of extracts from Gambierdiscus strains isolated in this study.
3. Discussion
CFP has been an issue in Australia for some time but very little is known about the toxicology
of the causative organism/s in this region. Prior to this study, strains from various Australian sites
had been identified but a thorough analysis of their toxicology had not been undertaken. Identifying
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the Gambierdiscus species and toxins responsible for CFP in Australia is a critical first step toward
improving risk management strategies and helping safeguard consumers and the seafood industry.
In this study, we established 14 strains of Gambierdiscus from eastern Australia, identifying four
Gambierdiscus species at a tropical site, two of which could represent new species, and one species at
a temperate site. Using a functional bioassay approach, we demonstrated that extracts of G. lapillus
and two other Gambierdiscus species (Gambierdiscus sp., UTSHI6A6 and UTSHI6B1) show CTX-like
activities. Furthermore, based on the LC-MS/MS results, we verified that this activity is not due to
CTXs for which we have standards and that are usually tested for in Gambierdiscus extracts (P-CTX-3C,
P-CTX-3B, P-CTX-4A, P-CTX-4B).
In this study, we uncovered considerable diversity of Gambierdiscus at the tropical site, recording
four co-occurring species from Heron Island, Queensland. G. carpenteri was the only species found to
occur at both the tropical and temperate locations (Merimbula, New South Wales). This species is one
of the most widely distributed in the genus, occurring in the North Atlantic Ocean [37,60], North Pacific
Ocean [13,36–38,61,62], South Pacific Ocean [60] and the Caribbean Sea [37,38]. In Australia,
G. carpenteri has previously been documented in the central Great Barrier Reef in Townsville,
Queensland [55,56], and at Merimbula and Wapengo Lagoon, New South Wales [57]. Our results,
therefore verify earlier reports of G. carpenteri from tropical and temperate Australia.
Gambierdiscus lapillus was also identified from the tropical site. It was described by
Kretzschmar et al. [58] from the same collection site at Heron Island and is currently the only other
record of this species. However, increased sampling and identification of Gambierdiscus species will
likely reveal a much larger distribution. Two additional strains of Gambierdiscus established in this
study (Gambierdiscus sp.) were not genetically identical to other currently described species within
the genus. These may represent additional undescribed species from Heron Island, although further
morphological and molecular identifications are required to verify this. A recently described species of
Gambierdiscus (G. honu) [40], has a wide distribution across the South Pacific Ocean, including Heron
Island [15], but this species was not isolated in our study. This result highlights that a single sample
collection and subsequent isolation process does not necessarily reveal all the diversity of a genus at
a specific location.
The LC-MS/MS analyses did not detect any characterized microalgal CTXs (P-CTX-3C, P-CTX-3B,
P-CTX-4A and P-CTX-4B) in any of the culture extracts. However, CTX-like activity was identified in
three of the four species tested. Previous studies of the toxicology of Gambierdiscus from Australia are
consistent with these results (Table 1). Using the same LC-MS/MS method, Kretzschmar et al. [58]
did not detect characterized microalgal CTXs in strains of G. lapillus isolated from Heron Island but
noted the presence of unassigned peaks in the CTX transition zone. Similarly, Kohli et al. [57] did not
detect characterized microalgal CTXs in a collection of G. carpenteri cells taken directly from the field
at Merimbula. The LC-MS/MS method used in these studies was targeted toward the identification
of P-CTX-3C, P-CTX-3B, P-CTX-4A and P-CTX-4B only, as these are the currently characterized
forms of microalgal origin for which standards are available. Structurally related compounds with
different masses are therefore not recognised. This indicates that the CTX-like activity detected using
the functional assay in our study, is likely caused by compounds which differ from the currently
characterized CTXs of microalgal origin.
Gambierdiscus sp. (UTSHI6A6) produced the most distinct CTX-activity peak eluting at
approximately 72 min. In a study using the same cell-based functional assay, Lewis et al. [38] identified
CTX-like activity which eluted at the same time in strains of G. ruetzleri (now Fukuyoa ruetzleri),
G. carolinianus and G. ribotype 2. However, LC-MS/MS analyses have not been performed on the
strains from Lewis et al. [38], so it is not known whether this activity is linked with known CTX
congeners. The results from our study suggest that this may be a novel type of lipophilic toxin with
CTX-like activity and its characterization should be the target of future research. Both strains of
G. lapillus also showed CTX-like activity, although the elution time of the active fractions differed
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between strains. These differences may arise from strains producing different congeners of a toxin;
however, understanding the reasons for such differences require further investigation.
Gambierdiscus sp. (UTSHI6B1) showed distinct CTX-like activity in a low polarity fraction collected
at approximately 29 min from the dichloromethane phase where lipophilic compounds like CTXs
accumulate. Known ciguatera toxins however, typically have higher polarities, so further research
is needed to accurately classify this active fraction. G. carpenteri strains from tropical and temperate
Australia did not show any distinct CTX-like activities, consistent with Lewis et al. [38] who tested two
strains of G. carpenteri (originally isolated from Belize in the Caribbean Sea and Hawaii in the eastern
North Pacific Ocean), using the same functional cell-based Ca2+ influx FLIPR bioassay. These results
suggest that G. carpenteri does not produce detectable quantities of ciguatera causing sodium channel
activation compounds and therefore, may not contribute to the occurrence of CFP.
Many Gambierdiscus species display toxicity in the lipophilic phase, following partitioning
in assays such as the mouse bioassay and the mammalian cell-based neuroblastoma (N2a) assay,
suggesting that CTXs or compounds with the same mode of action are present [16,36]. Efforts should
be focused on testing whether the toxicity of these strains can be attributed to the CTXs characterized
from French Polynesia, or whether toxins responsible for CFP differ between locations, as our findings
seem to suggest. Certainly, our results suggest the CTX-like toxins from Australia may differ from
those found in French Polynesia. CTXs isolated from marine fish also differ in structure from the
CTXs produced by Gambierdiscus species, a result of bioaccumulation and biomagnification; however,
the differences in the CTXs isolated from marine fish originating from different locations could suggest
that the precursor toxins produced by Gambierdiscus sp. are just as diverse.
Large MTX-like activities were identified in the dichloromethane phase of all Gambierdiscus
cell extracts, except for one strain of G. carpenteri isolated from temperate Australia. This was
unexpected, as MTXs should only be present in the methanol phase following liquid partitioning of the
microalgal cell extracts. However, the elution time of the MTX-like activity peak in the dichloromethane
phase corresponds to a fraction with strong MTX-like activity in the methanol phase and therefore,
likely represents a carryover of MTXs. Although liquid partitioning of lipophilic (CTX) and hydrophilic
(MTX) compounds in cell extracts using dichloromethane and aqueous methanol is effective, some MTX
carryover can occur. This was also observed at the same elution time in the original Ca2+ influx
SH-SY5Y cell FLIPR bioassay method description by Lewis et al. [38]. CTX-like activity was also
detected on the shoulders of this MTX-like activity. This is likely a result of sensitization of the sodium
channels on the mammalian cell membrane in response to the addition of veratridine, resulting in
a CTX-like activity peak and therefore, was not interpreted as an indicator of the presence of potential
CTXs in this study. The MTX peak was not detected in G. carpenteri strain UTSMER9A3; however,
CTX-like activity was. This was likely due to a lower level of MTX carryover from the methanol phase,
only high enough to show a response after the addition of veratridine.
Yasumoto et al. [11] were the first to establish the link between CFP and the dinoflagellate
Gambierdiscus. The structure of the microalgal derived CTXs responsible were later elucidated from
a strain (RG1-1) of Gambierdiscus (reported as G. toxicus but taxonomic identity is uncertain) isolated
from the Gambier Islands in French Polynesia [29,63–66]. Chinain et al. [23] then went on to complete
the first comprehensive characterization of CTXs from two highly toxic strains of G. polynesiensis
(TB-92 and RG-92) from French Polynesia, and the toxins characterized in these studies remain the
primary toxins linked with CFP today.
G. polynesiensis has been consistently found to exhibit considerable CTX-like activity (receptor
binding assay [23]; mouse bioassay [39]; neuro-2a Assay [67]) and is the only species shown to produce
the characterized CTXs when tested using LC-MS/MS analyses [23,39]. G. polynesiensis is therefore
thought to be an important contributor to CFP in the Pacific. Interestingly, a strain of G. polynesiensis
was recently isolated and found not to produce CTXs when tested with LC-MS/MS, but this is highly
unusual for this species [68]. Presently, only six strains of G. polynesiensis have been characterized
in the literature, four from French Polynesia [23], one from the Cook Islands [39] and one from the
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Kermadec Islands [68]. These locations are all situated within the central South Pacific Ocean but CFP
occurs across a much larger area (see review by Friedman et al. [3]), and CTXs are confirmed to be
present in fish from many locations [69–72]. Therefore, either the distribution of G. polynesiensis is
much larger than presently acknowledged, or there are other currently unidentified precursor toxins
that contribute to CFP in other locations.
Four congeners of MTX have been described, MTX-1, MTX-2, MTX-3 and MTX-4 [30,73,74] and
chemical detection methods exist for the two disulphated forms, MTX-1 and MTX-3. Using LC-MS/MS
analyses, we did not detect MTX-1 in any of the strains isolated in this study. This structural form of
MTX-1 was originally described from a strain of Gambierdiscus (FP) isolated from French Polynesia [73].
The species used for this original description is not known but MTX-1 has since only been identified in
strains of G. australes from the Cook Islands [39], the Kermadec Islands [68,75] and Japan [74].
MTX-3 is a putative MTX first described by Holmes and Lewis [30]. It is structurally smaller
than MTX-1 and MTX-2 but its complete structure, potency and mode of action remain unknown.
Since the original description, MTX-3 has been found in all Gambierdiscus strains tested (T. Harwood
pers comm), except for the temperate G. carpenteri strains isolated in this study [76]. The factors driving
the differences in MTX-3 production between the tropical and temperate populations of G. carpenteri
are unknown; however, our study shows that temperature is not one of them. MTX-4 is a recently
described congener of MTX, found only to be present in strains of G. excentricus isolated from a variety
of locations and is highly potent [74].
The Ca2+ influx SH-SY5Y cell FLIPR bioassay [38], showed that all strains of Gambierdiscus
isolated from eastern Australia produce between two and four peaks displaying MTX-like activities.
As LC-MS/MS analyses did not detect the presence of MTX-1 in these strains, the toxicity must
therefore be attributed to other types of MTX. Pisapia et al. [74] tested a wide range of Gambierdiscus
strains for the presence of the newly described toxin MTX-4 and found only G. excentricus produced
this compound. It is therefore unlikely that the MTX-like activity in the strains tested in this study
is related to the presence of MTX-4. Alternatively, MTX-2 was originally described from a strain of
Gambierdiscus (NQ1) isolated from the central Great Barrier Reef, Australia [73]. As there is no chemical
detection method for this congener of MTX, it is not known if any of the MTX-like activity peaks in this
study are from MTX-2, however it is likely as the original description was based on strains originating
from Australia.
MTXs are hydrophilic compounds and the likelihood of their contribution to human illness events
was originally discarded due to their water solubility [72]. However, recent work has confirmed that
MTXs can be retained in the viscera, liver and flesh of fish [77]. These recent findings, coupled with the
consistent detection of MTX-like activity in all Gambierdiscus strains tested in this study and by others
using functional assays (e.g., haemolytic activity [36,37], mouse bioassay [19,59] and the Ca2+ influx
SH-SY5Y cell FLIPR bioassay [38]), as well as the extremely high potency of these toxins, represent
compelling arguments toward the need for further investigations into the role of MTXs in CFP.
4. Materials and Methods
4.1. Sampling and Isolation
Epiphytes, including associated benthic microalgae, were removed from the surface of seagrass
(Zostera sp.) collected from the Merimbula Inlet, New South Wales, Australia (36.8979◦ S, 149.9044◦ E)
and macroalgae (Padina sp., Laurencia sp. and Chnoospora sp.) collected from the Heron Island lagoon,
Queensland, Australia (23.4423◦ S, 151.9148◦ E) on 7 April 2014 (austral autumn) and 27 July 2014
(austral winter), respectively.
Single cells of Gambierdiscus spp. were isolated using the micropipette technique [78] and placed
in individual wells of a 48-well clear microplate with 0.2 µm filtered sterilised and autoclaved seawater
collected from each site and incubated in a plant growth chamber (Labec, Sydney, NSW, Australia)
at 20 ◦C under ~100 µmol photons m−2 s−1 on a 12:12 light:dark cycle. Modified K medium [13]
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was gradually introduced as cells began to grow (i.e., 1:10 v/v, then increasing quantities until 1:1).
Once isolates reached a concentration of approximately 20 cells per well, each was transferred to
25 cm2 (50 mL) sterile vented polystyrene tissue culture flasks (Falcon, Corning, NY, USA), oriented
horizontally. Established cultures were then maintained in these vessels in modified K medium made
from sterile oceanic seawater (salinity was approximately 32 ppt), under ~100 µmol photons m−2 s−1
on a 12:12 light:dark cycle.
4.2. Strain Identification
Cells from approximately 100 mL of each Gambierdiscus culture were harvested by centrifugation
at 600× g for 10 min. DNA was extracted using a MoBio Soil DNA Extraction Kit following the
manufacturer’s instructions and sent to a commercial service (Australian Genomic Research Facility
(AGRF), Queensland, Australia) where the D1–D3 region of the large subunit (LSU) rDNA was
amplified using the primers D1R-F [79] and D3-R [80] and the D8–D10 region amplified using the
primers D8F and D10R [13]. These genetic markers were selected because they are commonly used for
the Gambierdiscus genus and many sequences are publicly available for comparison. PCR amplifications
were carried out in 50 µL reaction volumes containing AmpliTaq Gold 360 master mix, both forward
and reverse primers (2.5 µm) and template at a concentration of 1 ng µL−1. Thermocycling conditions
for the D1–D3 region were 95 ◦C for 5 min, 35 cycles at 95 ◦C for 30 s, 60 ◦C for 2 min, with a final step
at 72 ◦C for 10 min. Thermocycling conditions for the D8–D10 region were 95 ◦C for 5 min, 35 cycles at
95 ◦C for 30 s, 54 ◦C for 30 s, 72 ◦C for 1 min, with a final step at 72 ◦C for 5 min. Amplification products
(~950 bp) were purified and sequenced in both directions using the Sanger sequencing platform.
Phylogenetic analyses were conducted in Genious v9.1.5 [81]. Publicly available sequences of
Gambierdiscus spp. and sequences used as out-groups (Akashiwo sanguinea, Prorocentrum micans and
Alexandrium affine, A. catenella and A. tamarense) were downloaded from GenBank (www.ncbi.nlm.nih.
gov) and aligned with the sequences obtained from this study, using the MUSCLE algorithm (maximum
number of iterations 8) [82]. Sequences from the D1–D3 and D8–D10 regions were truncated to 979 bp
and 764 bp, respectively. Maximum Likelihood (ML) phylogenetic trees were generated for both regions
with PHYML with 1000 bootstraps [83] using a GTR substitution model and an estimated gamma
distribution. Bayesian analysis was performed for both regions using MrBayes 3.2.6 [84] by means
of the GTR+G (general-time reversible with gamma-shaped among-site variation) model. Bayesian
analyses were carried out in four simultaneous runs with four chains each for 3.1 × 106 generations,
sampling every 1000 trees and 1000 trees were discarded as burn in.
4.3. Toxicology
4.3.1. Detecting P-CTX-3B, P-CTX-3C, P-CTX-4A and P-CTX-4B Using Liquid Chromatography-Tandem
Mass Spectrometry (LC-MS/MS)
To test for the presence of CTXs commonly linked with CFP (P-CTX-3B, P-CTX-3C, P-CTX-4A,
P-CTX-4B), Gambierdiscus strains isolated in this study were cultured in triplicate 75 cm2
(250 mL) sterile vented polystyrene tissue culture flasks (Falcon, Corning, NY, USA), at 24 ◦C in
a temperature-controlled room under the maintenance conditions described above. To test the effect of
temperature on toxin production by the tropical and temperate strains of G. carpenteri, an experiment
was performed where cultures of the tropical and temperate strains (UTSHI2C4 and UTSMER9A3,
respectively) were grown at 18 or 27 ◦C in temperature-controlled plant growth cabinets (Climatron®,
Plant Growth Cabinet, Australia).
Cell growth was monitored using in vivo chlorophyll a fluorescence measurements. A 1 mL
aliquot was taken every 3 to 4 days from each flask and in vivo chlorophyll a fluorescence was
measured for each sample using a fluorometer (Turner Designs, Trilogy®, San Jose, CA, USA) and
then preserved with 1% Lugols iodine solution. Cultures were harvested in early stationary phase by
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centrifugation (3000× g for 10 min) and the three replicates were pooled to yield sufficient biomass
before being freeze dried until further LC-MS/MS analyses.
Lugols-preserved cells were used to estimate the number of cells in each cell pellet. The final
1 mL aliquot of culture collected prior to harvesting was counted using a Sedgewick Rafter Counting
Chamber under an inverted light microscope (× 100 magnification) (Nikon Instruments, Nikon Eclipse
TS100, Melville, NY, USA).
Analysis of selected CTXs was carried out using a quantitative LC-MS/MS method developed
at the Cawthron Institute (full method details will be disclosed in an upcoming manuscript by
T. Harwood). Microalgal pellets containing between 2.0 × 105 and 2.0 × 106 cells were extracted
in 1 mL of 100% MeOH in glass tubes, then mixed and sonicated for 5 min. Samples were transferred
to glass auto sampler vials using a glass pipette and 2 µL was injected for analysis. LC-MS/MS
analysis was performed on an Ultra Performance Liquid Chromatography (UPLC) coupled to a mass
spectrometer with electrospray ionization. Chromatographic separation used a BEH Phenyl column
eluted with ammoniated mobile phases; (A) Milli-Q and (B) acetonitrile. Starting conditions were
25% B followed by a stepped gradient to 95% B after 8 min, with re-equilibration to 25% B between
8 and 9 min. A flow rate 0.55 mL min−1 was used and the total run time was 9 min. Microalgal
CTX reference material (P-CTX-3B; P-CTX-3C; P-CTX-4A; P-CTX-4B) was supplied by Institut Louis
Malardé, French Polynesia.
MTX-1 (limit of detection of 1 ng mL−1) and putative MTX-3 were monitored as intact structures
using methods developed at Cawthron Institute [85,86]. Briefly, for MTX-1, a pseudo multiple reaction
monitoring (MRM) transition (m/z 1689.6 > 1689.6) was acquired for the intact di-anion with the
electrospray ionization source being operated in negative-ion mode. It was also possible to monitor
the presence of the sulphated polyether analyte known as MTX-3 using a specific MRM transition
(m/z 1037.6 > 96.8).
4.3.2. Ciguatoxin (CTX) and Maitotoxin-Like (MTX) Activities
Selected strains of Gambierdiscus (tropical G. carpenteri UTSHI2C4, UTSHI6C3; temperate G.
carpenteri UTSMER8B4, UTSMER9A3; G. lapillus UTSHI6B5, UTSHI2B6; Gambierdiscus sp. UTSHI6A6;
Gambierdiscus sp. UTSHI6B1) were analysed for CTX and MTX-like activities. Strains were grown
under standard conditions at 24 ◦C in a temperature-controlled room in 2 × 2 L glass Schott bottles.
Chlorophyll a in vivo fluorescence was used as a proxy for cell abundance to track growth and
duplicate bottles were pooled and harvested in the early stationary phase by first concentrating the
cells on a 20 µm sieve, followed by centrifugation (3000× g for 10 min). Total cell abundances ranged
between 1.0 × 106 and 3.5 × 106.
CTX and MTX-like activities were determined following the functional bioassay described by
Lewis et al. [38]. Briefly, cell pellets were extracted twice in a mix of analytical grade methanol:ultrapure
water:hexane (2:1:1) at a concentration of 10 mL per 1.0 × 106 cells and subsequently sonicated twice
for 1 min using a sonication probe (QSonica) at an amplitude of 50%. The extract was then centrifuged
to remove cell debris (600× g for 10 min) and the supernatant layers sampled. The hexane layer was
discarded and the remaining extract dried under N2 gas, then reconstituted in 10 mL dichloromethane
(DCM) and extracted twice with 5 mL 60% methanol (MeOH). The DCM lipophilic phase containing
CTXs (top layer) was then separated from the MeOH hydrophilic phase containing MTXs (bottom
layer) and each phase was dried separately under N2 gas in 20 mL amber glass vials.
The dried extracts were reconstituted in 30% acetonitrile (ACN)/0.1% formic acid (FA) and
approximately 1.0 × 106 microalgal cell equivalents were used for fractionation. Extracts were
fractionated on an UltiMate 3000 Rapid Separation Liquid Chromatography System (Dionex, IL,
USA) with a FC 204 Fraction Collector (Gilson, Middleton, WI, USA). Grace Vydac C18 (218TP)
Reverse-Phase HPLC Column (250 × 4.6 mm, 5 µm) (Grace Hichrom, Berkshire, UK) was used to
separate the extracts with 0.043% trifluoroacetic acid/90% acetonitrile (aq) as elution buffer B and
0.05% trifluoroacetic acid (aq) as buffer A. Initial elution was at 5% B for 5 min and then increased
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linearly to 90% B over 60 min at a flow rate of 0.7 mL min−1. 77 fractions were collected, freeze
dried and reconstituted in 30 µL physiological salt solution (PSS; composition NaCl 140 mM, glucose
11.5 mM, KCl 5.9 mM, MgCl2 1.4 mM, NaH2PO4 1.2 mM, NaHCO3 5 mM, CaCl2 1.8 mM, HEPES
10 mM) containing 0.1% bovine serum albumin (BSA) just prior to Ca2+ influx SH-SY5Y cell FLIPR
bioassay analysis.
Functional activity of extracts was then determined following Lewis et al. [38]. Briefly, SH-SY5Y
human neuronal cells (ECACC, Salisbury, Wiltshire, UK) were maintained in Roswell Park Memorial
Institute (RPMI) media containing 15% Foetal Bovine Serum (FBS) and 2 mM L-glutamine,
100 units mL−1 penicillin and 0.1 mg L−1 streptomycin at 37 ◦C, under 5% CO2 atmosphere. Cells were
routinely split once a week at a 1:5 dilution using 0.25% trypsin with ethylenediaminetetraacetic acid
(EDTA) (Gibco).
For the Ca2+ influx FLIPR bioassay, SH-SY5Y cells were planted into 384-well black walled imaging
plates (Corning, Australia) at a density of 50,000 cells per well and cultured for 48 h. Fluorescent
responses (excitation, 470–495 nm; emission, 515–575 nm) were assessed using the FLIPRTETRA
Fluorescent Imaging Plate Reader (Molecular Devices, Sunnydale, CA, USA) after a 30 min incubation
with a fluorescent Ca2+ dye (Calcium 4 No Wash Dye, Molecular Devices) diluted in PSS containing
0.1% BSA. Ten microliters of reconstituted HPLC fractions were added to each well and the fluorescence
response recorded for 5 min prior to stimulation with 5 µM veratridine. Signals were interpreted
as follows: If MTX-like activity was detected in the sample, calcium influx would be evident in this
early stage of the assay. If a second peak was detected in response to veratridine addition, this was
interpreted as an effect of CTX-like activity which acts to enhance an otherwise sub-effective dose of
veratridine. Positive control standards of P-CTX-2 and P-CTX-3 were used to verify CTX-like activity.
The assay detected P-CTX-2 at 9.51 ± 0.13 and P-CTX-3 at 9.26 ± 0.14, (pEC50, n = 2) in the presence of
5 µm veratridine, consistent with previous results using this assay by Lewis et al. [38].
FLIPR assay data were analysed using ScreenWorks 3.2.0.1.4 (Molecular Devices, Sunnydale, CA,
USA). For each fraction, the MTX-like activity was normalized to the baseline and the maximum peak
height in the following 300 reads represented the MTX-like response. CTX-like activity was normalized
to the veratridine response and the maximum peak height after the veratridine addition represented
the CTX-like response.
5. Conclusions
In this study, 14 strains of Gambierdiscus were established from eastern Australia, representing
four species. Extracts of three species showed CTX-like activity, likely caused by compounds which
are distinct from currently characterized toxins. These results suggest that toxins produced by these
Australian strains of Gambierdiscus likely differ from those currently linked with CFP identified
in extracts of G. polynesiensis from French Polynesia, though characterization of the compounds
responsible for the CTX-like activity is necessary to evaluate this. Although this study was limited
to Australian strains of Gambierdiscus, the findings are likely universal and therefore, a concentrated
effort should be made toward testing and characterizing the toxicology of strains from other locations.
Future research should also include establishing a baseline of Gambierdiscus species distribution in
Australia, understanding the relative abundance of each species and finding out how these organisms
are influenced by environmental conditions, particularly in view of a changing climate.
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